Patton, J.F., Spigel, D.R., Greco, F.A., Liggett, W.H., Zubkus, J.D., Baskette, M., Schreeder, M., Woytowitz, D., Nelson, E. and Hainsworth, J.D. (2006) Irinotecan [I], Carboplatin [C], and Radiotherapy [Rt] Followed by Maintenance Bevacizumab [b] in the Treatment [tx] of Limited-Stage Small Cell Lung Cancer [LS-SCLC]: Update of a Phase II Trial of the Minnie Pearl Cancer Research Network. Journal of Clinical Oncology, 24, 7085.

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.